Whole-exome sequencing predicts which bladder cancers, cell lines respond to cisplatin

A new study describes mutational landscape of bladder cancer cell lines, demonstrates that alterations in these cells lines do indeed match changes in samples of human bladder cancer and shows genes and gene pathways that may be functionally involved in the ability of bladder cancer to resist therapy.